APA citiranje

Wisinski, K. B., Ledesma, W. M., Kolesar, J., Wilding, G., Liu, G., Douglas, J., . . . Bailey, H. H. (2014). A Phase I Study to Determine the Maximum Tolerated Dose and Safety of Oral LR-103 (1α,24(S)Dihydroxyvitamin D(2)) in Patients with Advanced Cancer. J Oncol Pharm Pract.

Citação norma Chicago

Wisinski, Kari B., et al. "A Phase I Study to Determine the Maximum Tolerated Dose and Safety of Oral LR-103 (1α,24(S)Dihydroxyvitamin D(2)) in Patients With Advanced Cancer." J Oncol Pharm Pract 2014.

MLA citiranje

Wisinski, Kari B., et al. "A Phase I Study to Determine the Maximum Tolerated Dose and Safety of Oral LR-103 (1α,24(S)Dihydroxyvitamin D(2)) in Patients With Advanced Cancer." J Oncol Pharm Pract 2014.